J Nephropathol. 2017;6(3):144-149.
doi: 10.15171/jnp.2017.25
PMID: 28975094
PMCID: PMC5607975
Scopus id: 85019909769
  Abstract View: 1584
  PDF Download: 1281

Original Article

Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patient

Leila Mahmoodnia, Keivan Mohammadi * , Rohollah Masumi

1 Department of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
*Corresponding author: Keivan Mohammadi, Email: k1mohamadi@yahoo.com

Abstract

Background: Nephrotoxicity is one of the most important limitations of cisplatin-based chemotherapies which associated with many complications and high mortality rate.

Objectives: To investigate the effect of lycopene on cisplatin-induced nephrotoxicity in patients with cancer.

Patients and Methods: In this double-blind, randomized clinical trial, 120 patients were randomly assigned to two groups, case (treated with lycopene + standard regimen of kidney injury prevention) and control (treated with only the standard regimen of kidney injury prevention). Lycopene was orally taken from 24 hours before to 72 hours after cisplatin administration. Blood urea nitrogen (BUN), serum creatinine (Cr), and glomerular filtration rate (GFR) were measured and recorded. The data were analyzed using SPSS.

Results: Changes in Cr were not significantly different between the two groups (P = 0.131). However, a significant decreasing trend was seen in GFR during the study, which was more marked in the control group (P = 0.004). BUN significantly decreased during the study (P = 0.002), and a significant decrease of BUN on the day three in both groups was seen (P = 0.001). However, BUN increased in the case group on the day 21 of treatment. The corresponding increase was less marked in the control group.

Conclusions: Lycopene can be considered a useful adjuvant therapy to decrease the complications due to cisplatin-induced nephrotoxicity in patients with cancer.

Implication for health policy/practice/research/medical education:

Lycopene can be effective in decreasing the complications due to cisplatin-induced nephrotoxicity through affecting some markers of renal function. Therefore, use of lycopene, at appropriate doses, can be considered an adjuvant therapy, alongside chemotherapy and complementary therapy, to decrease the effects of nephrotoxicity.

Please cite this paper as: Mahmoodnia L, Mohammadi K, Masumi R. Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients. J Nephropathol. 2017;6(3):144-149. DOI: 10.15171/jnp.2017.25.

First name
 
Last name
 
Email address
 
Comments
 
Security code


Article Viewed: 1584

Your browser does not support the canvas element.


PDF Downloaded: 1281

Your browser does not support the canvas element.

First published online: 17 Jan 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)